This article, part of a special series in Blood on management of acquired hemolytic anemia, provides up-to-date clinical pearls and algorithms relevant to the diagnosis and management of wAIHA. It highlights standard treatment, newer targeted therapies, and approaches to wAIHA secondary to chronic lymphocytic leukemia. Several case-based discussions and helpful visuals are included.
Blood